Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clarithromycin as Immunomodulatory Therapy for the Management of Septic Syndrome by Ventilator-Associated Pneumonia

NCT00297674 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT00297674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clarithromycin as Immunomodulatory Therapy for the Management of Septic Syndrome by Ventilator-Associated Pneumonia
Lead sponsor
University of Athens
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
December 31, 2005
Enrollment
200
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, ventilator associated pneumonia